Search

everythinglearnresearchcommunity

for

Search:↓

Some chemicals and drugs can cause hair loss, which usually grows back after stopping the treatment.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Digital gangrene can be an initial symptom of late-onset systemic lupus erythematosus.

Monitor for early signs of myelosuppression, like hair loss, in patients on azathioprine to manage side effects.

Digital gangrene can be a rare first sign of late-onset systemic lupus erythematosus.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

A patient with pemphigus vulgaris improved significantly after treatment for an additional viral skin infection.

Mycophenolic acid effectively improved hair and nail growth in a lupus patient.

Stem cell research and regenerative medicine have made significant advancements in treating various diseases and conditions.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

A woman's severe insulin resistance improved with treatment, but she still had high testosterone levels due to ovarian issues.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

The document concludes that there have been significant advances in the treatment and diagnosis of various skin conditions.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.